Abstract
Phase 1b Study of BET Inhibitor PLX2853 in Patients with Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have